10162-1
10162-10
10162-5
CAYM10162-1EA
167
EUR
InStock
CAYM10162-1
CAYM10162-10
CAYM10162-5
Treprostinil ≥98%
Treprostinil
Treprostinil is a stable analog of prostacyclin that is used clinically for the treatment of PPH under the trade name Remodulin™. The structural modifications in treprostinil compared to prostacyclin increase the plasma half-life from 2 minutes to 34 and 85 minutes for intravenous and subcutaneous infusion of the drug, respectively
Attention: Warning - this product is not for human or veterinary use.